anticoagulant

Betrixaban: New Oral Blood Thinner Cleared by FDA

The U.S. Food and Drug Administration has granted Portola Pharmaceuticals permission to market …

Read the full story

Current News

January e-Newsletter | Connect with a Community that Cares

As 2019 gets underway, NBCA would like to take this opportunity to wish you a joyous and healthy year ahead.…

COVET Trial Opens for Enrollment

The COVET (Comparison of Oral anticoagulants for extended VEnous Thromboembolism) clinical trial is now open for enrollment. This study is…